Perspective
Our work in Perspective
-
Doctors Hold the Key to Lower Drug Prices
Contracts should raise awareness of cost without hurting patients’ access to necessary care. argues Senior Fellow Bob Kocher and his colleague Peter Orszag.
Categorized in -
Medicare’s ‘Catastrophic Insurance’ Can Be a Catastrophe for Middle-Income Seniors
Even with Medicare’s catastrophic insurance, middle-income seniors can be on the hook for thousands of dollars for their medications each year, write Erin Trish and Geoffrey Joyce in STAT.
Categorized in -
Mass Incarceration, Racial Disparities in Health, and Successful Aging
Over the past forty years, the United States has taken part in an experiment in mass incarceration. This article explores the impact that mass incarceration might have on successful aging and racial disparities in aging outcomes.
-
Coverage Gains Among Higher-Income People Suggest the ACA’s Individual Mandate Had Big Effects on Coverage
Matthew Fielder discusses the effects of the Affordable Care Act’s individual mandate and potential consequences of it’s repeal.
Categorized in -
New Payment Strategy Could Help States Treat More Hepatitis C Patients While Encouraging Innovation
A curative treatment exists for chronic hepatitis C infection, yet many Medicaid beneficiaries do not have access to these drugs. Neeraj Sood and his colleagues have developed a novel pricing strategy to expand access.
Categorized in -
The Case for Reforming Competitive Bidding in Medicare Advantage
Schaeffer Initiative experts propose reforming the way that fixed monthly payments to MA plans are determined, replacing the current, overly complex structure with one that would enhance competition, simplify beneficiary choice through standardization, and save an estimated $10 billion annually.
Categorized in -
Why Health Price Regulations in California are Misguided
Imposing uniform payment rates is dangerous and misguided, writes Trish and Goldman in the Sacramento Bee.
Categorized in -
Accelerating Alzheimer’s Disease Drug Innovations from the Research Pipeline to Patients
Goldman, Fillit, and Neumann outline policy options that would lead to more innovation.
Categorized in -
NAFTA Talks’ Potential Diabetes Threat
U.S. proposals to restrict junk food warnings will adversely affect the health of citizens in 3 countries writes Goldman and Gonzalez Gonzales in U.S. News
Categorized in -
Walmart and CVS Have 15,000 Combined Stores. Why are Both Trying to Buy Health Insurance Companies?
Trish and Goldman write these vertical megadeals will certainly disrupt care patterns and lower costs, but no one can know whether the savings will flow to shareholder or patients in the LA Times.
Categorized in